Evaluation of plasma EGFR mutation as an early predictor of...

EBioMedicine 2020 / 07 Vol. 57

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

Fukuhara, Tatsuro, Saito, Haruhiro, Furuya, Naoki, Watanabe, Kana, Sugawara, Shunichi, Iwasawa, Shunichiro, Tsunezuka, Yoshio, Yamaguchi, Ou, Okada, Prof Morihito, Yoshimori, Kozo, Nakachi, Ichiro, Ge
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
57
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2020.102861
Date:
July, 2020
File:
PDF, 1.02 MB
2020
Conversion to is in progress
Conversion to is failed